4.7 Article

PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41598-021-84278-7

Keywords

-

Funding

  1. Medical Research Council (MRC) UK [G0401310, G0802527, R011354/1]
  2. Parkinson's UK [G1404]
  3. Wellcome Trust [212247/Z/18/Z]
  4. MRC [G0400100, G0700091, GO802527, G0801680]
  5. Excellence Grant of the Luxembourg National Research Fund (FNR) within the PEARL programme (FNR) [FNR/P13/6682797]
  6. FNR within the National Centre of Excellence in Research on Parkinson's disease (NCER-PD) [NCER13/BM/11264123]
  7. Fonds National de la Recherche (FNR) Luxembourg/EU Joint Program-Neurodegenerative Disease Research (JPND) Project [INTER/JPND/15/11092422]
  8. German Ministry of Education and Research (BMBF) e:Med Demonstrator project MitoPD [FKZ 031A430A]
  9. Wellcome Trust [212247/Z/18/Z] Funding Source: Wellcome Trust
  10. MRC [G0401310, G0801680] Funding Source: UKRI

Ask authors/readers for more resources

Recent evidence suggests that neurogenesis continues throughout life but the impact on neurodegenerative disorders like Parkinson's disease is still unclear. Studies in zebrafish and human organoids show that PINK1 deficiency impairs adult dopaminergic neurogenesis, potentially affecting future therapeutic approaches for PD patients with biallelic PINK1 mutations.
Recent evidence suggests neurogenesis is on-going throughout life but the relevance of these findings for neurodegenerative disorders such as Parkinson's disease (PD) is poorly understood. Biallelic PINK1 mutations cause early onset, Mendelian inherited PD. We studied the effect of PINK1 deficiency on adult neurogenesis of dopaminergic (DA) neurons in two complementary model systems. Zebrafish are a widely-used model to study neurogenesis in development and through adulthood. Using EdU analyses and lineage-tracing studies, we first demonstrate that a subset of ascending DA neurons and adjacent local-projecting DA neurons are each generated into adulthood in wild type zebrafish at a rate that decreases with age. Pink1-deficiency impedes DA neurogenesis in these populations, most significantly in early adult life. Pink1 already exerts an early effect on Th1(+) progenitor cells rather than on differentiated DA neurons only. In addition, we investigate the effect of PINK1 deficiency in a human isogenic organoid model. Global neuronal differentiation in PINK1-deficient organoids and isogenic controls is similar, but PINK1-deficient organoids display impeded DA neurogenesis. The observation of impaired adult dopaminergic neurogenesis in Pink1 deficiency in two complementing model systems may have significant consequences for future therapeutic approaches in human PD patients with biallelic PINK1 mutations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

Semra Smajic, Cesar A. Prada-Medina, Zied Landoulsi, Jenny Ghelfi, Sylvie Delcambre, Carola Dietrich, Javier Jarazo, Jana Henck, Saranya Balachandran, Sinthuja Pachchek, Christopher M. Morris, Paul Antony, Bernd Timmermann, Sascha Sauer, Sandro L. Pereira, Jens C. Schwamborn, Patrick May, Anne Gruenewald, Malte Spielmann

Summary: In this study, the contribution of different cell types to Parkinson's disease pathology was investigated using single-nuclei RNA sequencing. The results revealed a disease-specific neuronal cell cluster and changes in glial cells, as well as the enrichment of Parkinson's disease risk genes. These findings highlight the importance of inflammatory signaling and immunomodulatory treatments in Parkinson's disease.

BRAIN (2022)

Article Clinical Neurology

Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment

Javier Jarazo, Kyriaki Barmpa, Jennifer Modamio, Claudia Saraiva, Sonia Sabate-Soler, Isabel Rosety, Anne Griesbeck, Florian Skwirblies, Gaia Zaffaroni, Lisa M. Smits, Jihui Su, Jonathan Arias-Fuenzalida, Jonas Walter, Gemma Gomez-Giro, Anna S. Monzel, Xiaobing Qing, Armelle Vitali, Gerald Cruciani, Ibrahim Boussaad, Francesco Brunelli, Christian Jager, Aleksandar Rakovic, Wen Li, Lin Yuan, Emanuel Berger, Giuseppe Arena, Silvia Bolognin, Ronny Schmidt, Christoph Schroeder, Paul M. A. Antony, Christine Klein, Rejko Kruger, Philip Seibler, Jens C. Schwamborn

Summary: This study investigated the differences between neurons derived from Parkinson's disease patients and controls, identifying potential pathways for targeted treatment. By correcting mutations and using a specific compound, improvements in metabolic properties and neuronal differentiation in patient-derived cells were observed. Treatment with a repurposed compound was shown to restore impaired dopaminergic differentiation in Parkinson's disease patient-derived cells.

MOVEMENT DISORDERS (2022)

Article Neurosciences

Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality

Sonia Sabate-Soler, Sarah Louise Nickels, Claudia Saraiva, Emanuel Berger, Ugne Dubonyte, Kyriaki Barmpa, Yan Jun Lan, Tsukasa Kouno, Javier Jarazo, Graham Robertson, Jafar Sharif, Haruhiko Koseki, Christian Thome, Jay W. Shin, Sally A. Cowley, Jens C. Schwamborn

Summary: The absence of microglia in current midbrain organoid systems limits the study of neuronal networks and neuroinflammation-related diseases. This study successfully derived microglia from human iPSCs and integrated them into midbrain organoids, shedding light on the role of microglia in influencing other cells in the organoids.
Article Clinical Neurology

Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation

Kobi Wasner, Semra Smajic, Jenny Ghelfi, Sylvie Delcambre, Cesar A. Prada-Medina, Evelyn Knappe, Giuseppe Arena, Patrycja Mulica, Gideon Agyeah, Aleksandar Rakovic, Ibrahim Boussaad, Katja Badanjak, Jochen Ohnmacht, Jean-Jacques Gerardy, Masashi Takanashi, Joanne Trinh, Michel Mittelbronn, Nobutaka Hattori, Christine Klein, Paul Antony, Philip Seibler, Malte Spielmann, Sandro L. Pereira, Anne Gruenewald

Summary: “Parkin plays a crucial role in regulating mitophagy, mitochondrial biogenesis, and mtDNA maintenance, protecting midbrain neurons from neuroinflammation and degeneration.”

MOVEMENT DISORDERS (2022)

Article Biology

GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton

Christina Wolf, Alireza Pouya, Sara Bitar, Annika Pfeiffer, Diones Bueno, Sabine Arndt, Stefan Tenzer, Federica Dal Bello, Caterina Vianello, Sandra Ritz, Jonas Schwirz, Kristina Dobrindt, Michael Peitz, Eva-Maria Hanschmann, Ibrahim Boussaad, Oliver Brustle, Marta Giacomello, Rejko Kruger, Axel Methner, Liliana Rojas-Charry, David Gomez-Zepeda, Pauline Mencke, Marion Silies, Oliver Brustle

Summary: GDAP1 mutations in Charcot-Marie-Tooth disease 4A inhibit the pyruvate dehydrogenase complex and restrict the localization of dynamin-related protein 1 in mitochondria through alterations of actin signaling. This study provides insights into the underlying mechanism of GDAP1-associated phenotypes and highlights the role of disrupted actin signaling in CMT4A pathophysiology.

COMMUNICATIONS BIOLOGY (2022)

Article Cell & Tissue Engineering

Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson?s disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1)

Pauline Mencke, Zoe Hanss, Javier Jarazo, Francois Massart, Arkadiusz Rybicki, Elizabet Petkovski, Enrico Glaab, Ibrahim Boussaad, Vincenzo Bonifati, Jens Christian Schwamborn, Wim Mandemakers, Rejko Krueger

Summary: In this study, an isogenic control cell line was generated using CRISPR/Cas9 technology to correct the disease-causing mutation in the PARK7 gene in a Parkinson's disease patient. This cell line will be used for phenotype analysis of neurons and astrocytes derived from the patient.

STEM CELL RESEARCH (2022)

Article Multidisciplinary Sciences

Generalising from conventional pipelines using deep learning in high-throughput screening workflows

Beatriz Garcia Santa Cruz, Jan Slter, Gemma Gomez-Giro, Claudia Saraiva, Sonia Sabate-Soler, Jennifer Modamio, Kyriaki Barmpa, Jens Christian Schwamborn, Frank Hertel, Javier Jarazo, Andreas Husch

Summary: The study focuses on addressing the challenges of data acquisition and image analysis in complex disease research. By combining traditional computer vision methods with deep learning, the research team successfully trained a deep learning network and improved the segmentation quality using automatically generated labels. The user-friendly graphical interface allows researchers to evaluate and correct the predictions. Furthermore, the study demonstrates the feasibility of training a deep learning solution on a large dataset of noisy labels.

SCIENTIFIC REPORTS (2022)

Review Cell Biology

Bone Tissue and the Nervous System: What Do They Have in Common?

Arianna Minoia, Luca Dalle Carbonare, Jens Christian Schwamborn, Silvia Bolognin, Maria Teresa Valenti

Summary: Degenerative diseases affecting bone tissues and the brain have significant socioeconomic impact. Osteoporosis and neurodegenerative diseases are often linked, with bone fractures and reduced mobility being common in patients. Bone is not only involved in movement but also plays a role in mineral metabolism and the production of stem cells. The interaction between the nervous system and bone is bidirectional, with bone influencing neuronal regulation and vice versa. This review summarizes recent knowledge on this interaction and emphasizes its importance. Experimental models and suggestions for evaluating molecular interactions between nerve and skeletal cells are also discussed.

CELLS (2023)

Article Cell Biology

Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids

Maria Meszaros, Thi Ha My Phan, Judit P. Vigh, Gergo Porkolab, Anna Kocsis, Emese K. Pali, Tamas F. Polgar, Fruzsina R. Walter, Silvia Bolognin, Jens C. Schwamborn, Jeng-Shiung Jan, Maria A. Deli, Szilvia Veszelka

Summary: Research has found that nanoparticles targeting cerebral endothelial cells can enhance drug delivery to the brain. By combining alanine and glutathione, these polypeptide nanocarriers showed increased permeability and cellular uptake in a co-culture model of human endothelial cells and brain pericytes. These findings suggest that poly(l-glutamic acid) nanoparticles can be effective nanocarriers for drug delivery to the nervous system.

CELLS (2023)

Article Cell & Tissue Engineering

p Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson?s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p. T610A) in the RHOT1 gene encoding Miro1

Axel Chemla, Giuseppe Arena, Claudia Saraiva, Clara Berenguer-Escuder, Dajana Grossmann, Anne Grunewald, Christine Klein, Philip Seibler, Jens C. Schwamborn, Rejko Kruger

Summary: In this study, two Parkinson's disease patients' primary skin fibroblasts carrying distinct heterozygous mutations in the RHOT1 gene encoding Miro1 were reprogrammed into induced pluripotent stem cells (iPSCs) using episomal reprogramming. Isogenic gene-corrected lines were generated using CRISPR/Cas9 technology. Both isogenic pairs were comprehensively characterized and quality assured to study the Miro1-related molecular mechanisms underlying neurodegeneration in iPSC-derived neuronal models.

STEM CELL RESEARCH (2023)

Article Medicine, Research & Experimental

The Future of Parkinson?s Disease Research A New Paradigm of Human Specific Investigation Is Necessary ... and Possible ...

Manuela Cassotta, Hugo Geerts, Lise Harbom, Tiago F. Outeiro, Iosif Pediaditakis, Orly Reiner, Stefan Schildknecht, Jens C. Schwamborn, Jarrod Bailey, Kathrin Herrmann, Helena T. Hogberg

Summary: Parkinson's disease (PD) is a complex neurodegenerative condition with a lack of preventive or curative therapies. New approach methodologies (NAMs) hold potential to advance PD research and reduce the reliance on animal-based studies. Key recommendations to advance PD research include integrating NAMs, learning from other neurodegenerative diseases, increasing data sharing, promoting innovative pilot studies, and accessing philanthropic funding.

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2022)

No Data Available